PRVA Stock Recent News

Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants David Mountcastle - Executive VP, CFO & Principal Accounting Officer Parth Mehrotra - CEO & Director Robert P. Borchert - Senior Vice President of Investor Relations & Corporate Communications Conference Call Participants Albert J.

Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.03 per share a year ago.

Strong Performance Across Key Metrics; Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution, Adj EBITDA

ARLINGTON, Va., July 10, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods ended June 30, 2025 before market open on Thursday, August 7, 2025.

Berberian brings significant technology leadership and cybersecurity expertise Berberian brings significant technology leadership and cybersecurity expertise

Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor and Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Jailendra Singh - Truist Josh Raskin - Nephron Research Richard Close - Canaccord Matthew Gillmor - KeyBanc Jessica Tassan - Piper Sandler Alberta Massey - Leerink Partners A.J. Rice - UBS Thomas Walsh - Barclays Ryan Langston - TD Cowen Elizabeth Anderson - Evercore ISI Constantine Davides - Citizens JMP Jack Slevin - Jefferies Jeff Garro - Stephens Ryan Daniels - William Blair David Larsen - BTIG Matt Shea - Needham Jamie Perse - Goldman Sachs Daniel Grosslight - Citi Michael Ha - Baird Joanna Gajuk - Bank of America Operator Thank you for standing by.

While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago.

Strong First Quarter Performance and Operating Execution Enters the State of Arizona Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2025.